Lorrain Daniel S.
Chief Scientific Officer · 27 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-09 | CTNM | Contineum Therapeutics, Inc. | Sale | 25 | $16.00 | $400.00 | filing |
| 2026-07-09 | CTNM | Contineum Therapeutics, Inc. | Option exercise | 25 | $1.01 | $25.25 | filing |
| 2026-07-08 | CTNM | Contineum Therapeutics, Inc. | Sale | 1,015 | $16.00 | $16,240.00 | filing |
| 2026-07-08 | CTNM | Contineum Therapeutics, Inc. | Option exercise | 1,015 | $1.01 | $1,025.15 | filing |
| 2026-07-01 | CTNM | Contineum Therapeutics, Inc. | Sale | 5,852 | $15.67 | $91,681.53 | filing |
| 2026-07-01 | CTNM | Contineum Therapeutics, Inc. | Sale | 2,501 | $16.24 | $40,608.49 | filing |
| 2026-07-01 | CTNM | Contineum Therapeutics, Inc. | Option exercise | 4,183 | $1.01 | $4,224.83 | filing |
| 2026-06-30 | CTNM | Contineum Therapeutics, Inc. | Sale | 28,826 | $16.04 | $462,288.33 | filing |
| 2026-06-30 | CTNM | Contineum Therapeutics, Inc. | Option exercise | 28,826 | $1.01 | $29,114.26 | filing |
| 2026-06-01 | CTNM | Contineum Therapeutics, Inc. | Sale | 4,170 | $13.16 | $54,862.19 | filing |
| 2026-05-01 | CTNM | Contineum Therapeutics, Inc. | Sale | 3,870 | $13.06 | $50,542.20 | filing |
| 2026-05-01 | CTNM | Contineum Therapeutics, Inc. | Sale | 300 | $13.84 | $4,152.00 | filing |
| 2026-04-06 | CTNM | Contineum Therapeutics, Inc. | Sale | 4,170 | $13.43 | $56,013.94 | filing |
| 2026-03-02 | CTNM | Contineum Therapeutics, Inc. | Sale | 4,170 | $15.01 | $62,585.03 | filing |
| 2026-02-25 | CTNM | Contineum Therapeutics, Inc. | Sale | 3,824 | $16.01 | $61,227.98 | filing |
| 2026-02-25 | CTNM | Contineum Therapeutics, Inc. | Option exercise | 3,824 | $1.01 | $3,862.24 | filing |
| 2026-02-24 | CTNM | Contineum Therapeutics, Inc. | Sale | 4,300 | $16.03 | $68,935.88 | filing |
| 2026-02-24 | CTNM | Contineum Therapeutics, Inc. | Option exercise | 4,300 | $1.01 | $4,343.00 | filing |
| 2026-02-19 | CTNM | Contineum Therapeutics, Inc. | Sale | 100 | $16.00 | $1,600.00 | filing |
| 2026-02-19 | CTNM | Contineum Therapeutics, Inc. | Option exercise | 100 | $1.01 | $101.00 | filing |
| 2026-02-11 | CTNM | Contineum Therapeutics, Inc. | Sale | 400 | $16.00 | $6,400.00 | filing |
| 2026-02-11 | CTNM | Contineum Therapeutics, Inc. | Option exercise | 400 | $1.01 | $404.00 | filing |
| 2026-02-03 | CTNM | Contineum Therapeutics, Inc. | Sale | 3,000 | $14.82 | $44,468.70 | filing |
| 2026-02-03 | CTNM | Contineum Therapeutics, Inc. | Sale | 1,170 | $15.25 | $17,836.77 | filing |
| 2026-01-05 | CTNM | Contineum Therapeutics, Inc. | Sale | 3,670 | $10.35 | $37,978.26 | filing |
| 2026-01-05 | CTNM | Contineum Therapeutics, Inc. | Sale | 500 | $11.13 | $5,564.90 | filing |
| 2025-12-23 | CTNM | Contineum Therapeutics, Inc. | Sale | 4,170 | $12.23 | $51,009.11 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.